Photocure was founded by the Norwegian Radium Hospital Research Foundation (RF) to commercialise and develop technologies originally discovered by scientists at the Norwegian Radium Hospital.
Photocure uses a global network of academic institutions and third party contract research organisations to give the company access to world-class research at an affordable cost. Collaborations with academic institutions will always remain a core part of Photocure's strategy for developing new products and platform technologies.
Ongoing clinical studies
Photocure has initiated clinical pilot studies in patients with colorectal cancer and cervical pre-malignancies to show the feasibility of these procedures. Positive results will initiate larger clinical programs to document clinical benefits.